日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Impact of clinical factors and season on inflammatory cytokines in biologic-treated and untreated asthma

临床因素和季节对生物制剂治疗和未治疗哮喘患者炎症细胞因子的影响

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-025-03373-9
Nopsopon, Tanawin; Cabrera-Perez, Javier; Lee, Pui Y; Brodeur, Kailey E; Lugogo, Njira L; Hsu, Evan E; LeSon, Courtney; Hahn, Georg; Carr, Steven A; Weiss, Scott T; Akenroye, Ayobami
哮喘
炎症
炎症/感染
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Cannabis and cannabinoids in dermatology: a systematic review and meta-analysis of quantitative outcomes

大麻及大麻素在皮肤病学中的应用：定量结果的系统评价和荟萃分析

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1609667
Sermsaksasithorn, Pim; Nopsopon, Tanawin; Samuthpongtorn, Chatpol; Chotirosniramit, Korn; Pongpirul, Krit
发表日期：2025
文献求助 收藏

Correction: Thu et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology 2023, 12, 280

更正：Thu 等人，《益生菌对乳腺癌的影响：系统评价和荟萃分析》，《生物学》2023，12，280

期刊:Biology-Basel
影响因子:3.5
doi:10.3390/biology14080991
Thu, May S; Ondee, Thunnicha; Nopsopon, Tanawin; Farzana, Izzati A K; Fothergill, Joanne L; Hirankarn, Nattiya; Campbell, Barry J; Pongpirul, Krit
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma

基于机器学习的遗传风险评分表明，IL21 可预测哮喘患者对奥马珠单抗和度普利尤单抗的反应。

期刊:Frontiers in Allergy
影响因子:3.1
doi:10.3389/falgy.2025.1670783
Akenroye, Ayobami; Zhang, Chengyue; Nopsopon, Tanawin; Kalra, Sean; Weiss, Scott T; Moll, Matthew R
哮喘
IL2
发表日期：2025
文献求助 收藏

Patients with Higher Exacerbation Burden and Eosinophil Counts are More Likely to Require Multiple Biologics for Asthma Control

哮喘急性发作频率较高和嗜酸性粒细胞计数较高的患者更可能需要多种生物制剂来控制哮喘。

期刊:Journal of Asthma and Allergy
影响因子:3
doi:10.2147/JAA.S543815
Brown, Alyson N; Nopsopon, Tanawin; Akenroye, Ayobami
细胞生物学
哮喘
粒细胞
发表日期：2025
文献求助 收藏

Inborn Errors of Immunity Presenting with Early-Onset Severe Atopy

先天性免疫缺陷伴早发性严重特应性皮炎

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina61010062
Chuleerarux, Nipat; Makkoukdji, Nadia; Satnarine, Travis; Kuhn, Jessica Elise; Nopsopon, Tanawin; Valyasevi, Peerada; Schmidt, Fernanda Bellodi; Kleiner, Gary; Gans, Melissa
免疫/内分泌
发表日期：2025
文献求助 收藏

Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab

一组接受美泊利单抗、奥马珠单抗或度普利尤单抗治疗的中重度哮喘患者的肺功能轨迹

期刊:Allergy
影响因子:12
doi:10.1111/all.16002
Nopsopon, Tanawin; Barrett, Nora A; Phipatanakul, Wanda; Laidlaw, Tanya M; Weiss, Scott T; Akenroye, Ayobami
哮喘
发表日期：2024
文献求助 收藏

Serum Galactomannan: A Predictor of Poor Outcomes in Peritoneal Dialysis Patients With Fungal Peritonitis

血清半乳甘露聚糖：腹膜透析合并真菌性腹膜炎患者预后不良的预测因子

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2023.11.002
Kanjanabuch, Talerngsak; Nopsopon, Tanawin; Saejew, Thunvarat; Banjongjit, Athiphat; Puapatanakul, Pongpratch; Tungsanga, Somkanya; Vanichanan, Jakapat; Tatiyanupanwong, Sajja; Tianprasertkij, Kanjana; Treamtrakanpon, Worapot; Parinyasiri, Uraiwan; Khositrangsikun, Kamol; Thamvichitkul, Oranan; Lorvinitnun, Pichet; Uppamai, Sriphrae; Lawsuwanakul, Rhonachai; Wanpaisitkul, Mananya; Chowpontong, Saowalak; Chieochanthanakij, Rutchanee; Eiam-Ong, Somchai; Perl, Jeffrey; Johnson, David W
微生物学
发表日期：2024
文献求助 收藏

Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma

非靶向代谢组学分析揭示了与哮喘患者对美泊利单抗和奥马珠单抗的反应相关的不同代谢物

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00931-2023
Nopsopon, Tanawin; Chen, Yulu; Chen, Qingwen; Wheelock, Craig E; Weiss, Scott T; McGeachie, Michael; Lasky-Su, Jessica; Akenroye, Ayobami
哮喘
代谢
发表日期：2024
文献求助 收藏

Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics

生物制剂治疗哮喘疗效的时间变化：患者特征改变对疗效的影响

期刊:Respiratory Medicine
影响因子:3.1
doi:10.1016/j.rmed.2024.107802
Nopsopon, Tanawin; Brown, Alyson; Hahn, Georg; Rank, Matthew; Huybrechts, Krista F; Akenroye, Ayobami
哮喘
发表日期：2024
文献求助 收藏